TY - JOUR
T1 - Secondary individual outcomes following multicouple group therapy for posttraumatic stress disorder
T2 - An uncontrolled pilot study with military dyads
AU - for the Consortium to Alleviate PTSD
AU - Macdonald, Alexandra
AU - Fredman, Steffany J.
AU - Taylor, Daniel J.
AU - Pruiksma, Kristi E.
AU - Blount, Tabatha H.
AU - Hall-Clark, Brittany N.
AU - Fina, Brooke A.
AU - Dondanville, Katherine A.
AU - Mintz, Jim
AU - Litz, Brett T.
AU - Young-McCaughan, Stacey
AU - Le, Yunying
AU - Jenkins, August I.C.
AU - Monson, Candice M.
AU - Yarvis, Jeffrey S.
AU - Keane, Terence M.
AU - Peterson, Alan L.
N1 - Funding Information:
This research is supported by the Consortium to Alleviate PTSD (CAP) with funding from the U.S. Department of Defense, Defense Health Program, Psychological Health and Traumatic Brain Injury Research Program (PH/TBI RP; W81XWH‐13‐2‐0065), and the U.S. Department of Veterans Affairs, Office of Research & Development, Clinical Science Research & Development Service(I01CX001136‐01). Additional funding was provided by the Karl R. Fink and Diane Wendle Fink Early Career Professorship for the Study of Families and startup funds from The Pennsylvania State University (Steffany J. Fredman); the National Center for Advancing Translational Sciences, which provided funding to the Pennsylvania State University (KL2 TR000126 and TR002015); and the Military Health Institute at The University of Texas Health Science Center at San Antonio.
Funding Information:
informationThe Pennsylvania State University; U.S. Department of Veterans Affairs, Grant/Award Number: I01CX001136-01; U.S. Department of Defense, Grant/Award Number: W81XWH-13-2-0065; The National Institutes of Health, Grant/Award Number: KL2 TR000126 and TR002015.
Publisher Copyright:
© 2021 International Society for Traumatic Stress Studies
PY - 2022/2
Y1 - 2022/2
N2 - Cognitive-behavioral conjoint therapy (CBCT) for posttraumatic stress disorder (PTSD) has demonstrated efficacy for improving PTSD and comorbid symptoms and relationship adjustment. To enhance treatment efficiency and scalability, we developed a 2-day, abbreviated, intensive, multicouple group version of CBCT for PTSD (AIM-CBCT for PTSD). Prior work demonstrated that AIM-CBCT for PTSD wasassociated with reductions in PTSD and comorbid symptoms in a sample of 24 post-9/11 active duty military or veteran couples who received the treatment in a retreat format over a single weekend. The current study investigated secondary outcomes regarding trauma-related cognitions, psychosocial impairment, and insomnia. For trauma-related cognitions, reductions were nonsignificant and small at 1-month follow-up, ds = −0.14 to −0.32. However, by 3-month follow-up, there were significant, medium effect size reductions in total trauma-related cognitions, d = −0.68, and negative views of self and others, ds = −0.64 and −0.57, respectively, relative to baseline. There was also a nonsignificant, small-to-medium effect-size reduction in self-blame, d = −0.43, p =.053, by 3-month follow-up. For psychosocial impairment, there were significant and medium-to-large and large effect size reductions by 1- and 3-month follow-ups, ds = −0.73 and −0.81, respectively. There were nonsignificant, small effect size reductions in insomnia at both 1- and 3-month follow-ups relative to baseline, ds = −0.30 and −0.34, respectively. These findings suggest that AIM-CBCT for PTSD is associated with reductions in maladaptive posttraumatic cognitions and psychosocial impairment but that adjunctive interventions may be needed to address insomnia.
AB - Cognitive-behavioral conjoint therapy (CBCT) for posttraumatic stress disorder (PTSD) has demonstrated efficacy for improving PTSD and comorbid symptoms and relationship adjustment. To enhance treatment efficiency and scalability, we developed a 2-day, abbreviated, intensive, multicouple group version of CBCT for PTSD (AIM-CBCT for PTSD). Prior work demonstrated that AIM-CBCT for PTSD wasassociated with reductions in PTSD and comorbid symptoms in a sample of 24 post-9/11 active duty military or veteran couples who received the treatment in a retreat format over a single weekend. The current study investigated secondary outcomes regarding trauma-related cognitions, psychosocial impairment, and insomnia. For trauma-related cognitions, reductions were nonsignificant and small at 1-month follow-up, ds = −0.14 to −0.32. However, by 3-month follow-up, there were significant, medium effect size reductions in total trauma-related cognitions, d = −0.68, and negative views of self and others, ds = −0.64 and −0.57, respectively, relative to baseline. There was also a nonsignificant, small-to-medium effect-size reduction in self-blame, d = −0.43, p =.053, by 3-month follow-up. For psychosocial impairment, there were significant and medium-to-large and large effect size reductions by 1- and 3-month follow-ups, ds = −0.73 and −0.81, respectively. There were nonsignificant, small effect size reductions in insomnia at both 1- and 3-month follow-ups relative to baseline, ds = −0.30 and −0.34, respectively. These findings suggest that AIM-CBCT for PTSD is associated with reductions in maladaptive posttraumatic cognitions and psychosocial impairment but that adjunctive interventions may be needed to address insomnia.
UR - http://www.scopus.com/inward/record.url?scp=85119400466&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85119400466&partnerID=8YFLogxK
U2 - 10.1002/jts.22729
DO - 10.1002/jts.22729
M3 - Article
C2 - 34800060
AN - SCOPUS:85119400466
VL - 35
SP - 321
EP - 329
JO - Journal of Traumatic Stress
JF - Journal of Traumatic Stress
SN - 0894-9867
IS - 1
ER -